Eli Lilly Expands Gene Therapy Portfolio to Eye Care with $475M MeiraGTx Deal
Eli Lilly bets big on the future of gene therapy for vision restoration. Eli Lilly is making another bold move…
PolyActiva and RareSight Join Forces to Target Rare Pediatric Retinal Diseases
In a move that could reshape how IRDs are treated, two innovative companies are joining forces to make long-lasting vision…
popular posts
latest posts
